Hillhouse Capital Management - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Hillhouse Capital Management ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$49,646,000
+63.3%
949,431
+35.7%
1.33%
+156.2%
Q2 2018$30,397,000
+17.3%
699,4310.0%0.52%
+13.3%
Q1 2018$25,914,000
+190.3%
699,431
+55.4%
0.46%
+200.7%
Q4 2017$8,928,000
-20.3%
450,0000.0%0.15%
-17.8%
Q3 2017$11,201,000
+42.7%
450,0000.0%0.18%
+52.9%
Q2 2017$7,848,000450,0000.12%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
ALGERT GLOBAL LLC 68,100$980.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
View complete list of G1 THERAPEUTICS INC shareholders